drugset / Trial / NCT00115115
Donor Dopamine and Initial Graft Function
Phase 4
Completed
487 enrolled
University Medical Center Mannheim
Eurotransplant International Foundation, Leiden, The Netherlands · collabNovartis · collabRegional Organ Procurement Organization (DSO), Baden-Wuerttemberg, Germany · collabRegional Organ Procurement Organization (DSO), Bavaria, Germany · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Donor pre-treatment with dopamine reduces injury to the kidney graft with consequences on the clinical performance immediately after transplantation: Donor dopamine reduces the requirement of dialysis post transplant, and results in renal function improvements. The purpose of the study is to investigate the potentially therapeutic impact of donor preconditioning with low dose dopamine in human renal transplant recipients from a brain dead donor.
Timeline
- Start
- 2004-03
- Primary completion
- 2007-12
- Completion
- 2009-03
Publications
- Background Schnuelle P, Yard BA, Braun C, Dominguez-Fernandez E, Schaub M, Birck R, Sturm J, Post S, van der Woude FJ. Impact of donor dopamine on immediate graft function after kidney transplantation. Am J Transplant. 2004 Mar;4(3):419-26. doi: 10.1111/j.1600-6143.2004.00331.x.
- Background Yard B, Beck G, Schnuelle P, Braun C, Schaub M, Bechtler M, Gottmann U, Xiao Y, Breedijk A, Wandschneider S, Losel R, Sponer G, Wehling M, van der Woude FJ. Prevention of cold-preservation injury of cultured endothelial cells by catecholamines and related compounds. Am J Transplant. 2004 Jan;4(1):22-30. doi: 10.1046/j.1600-6143.2003.00268.x.
- Background Schnuelle P, Berger S, de Boer J, Persijn G, van der Woude FJ. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation. 2001 Aug 15;72(3):455-63. doi: 10.1097/00007890-200108150-00017.
- Background Schnuelle P, Lorenz D, Mueller A, Trede M, Van Der Woude FJ. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int. 1999 Aug;56(2):738-46. doi: 10.1046/j.1523-1755.1999.00567.x.
- Benck U, Jung M, Kruger B, Grimm A, Weiss C, Yard BA, Lehner F, Kiessling A, Fischer L, Gallinat A, Kleespies A, Lorf T, Sucher R, Monch C, Scherer MN, Rahmel A, Schemmer P, Kramer BK, Schnuelle P. Donor Dopamine Does Not Affect Liver Graft Survival: Evidence of Safety From a Randomized Controlled Trial. Liver Transpl. 2018 Oct;24(10):1336-1345. doi: 10.1002/lt.25301.
- Schnuelle P, Benck U, Kramer BK, Yard BA, Zuckermann A, Wagner F, Szabo G, Borggrefe M, Karck M, Gummert J. Impact of Donor Core Body Temperature on Graft Survival After Heart Transplantation. Transplantation. 2018 Nov;102(11):1891-1900. doi: 10.1097/TP.0000000000002337.
- Schnuelle P, Mundt HM, Druschler F, Schmitt WH, Yard BA, Kramer BK, Benck U. Impact of spontaneous donor hypothermia on graft outcomes after kidney transplantation. Am J Transplant. 2018 Mar;18(3):704-714. doi: 10.1111/ajt.14541. Epub 2017 Nov 22.
- Schnuelle P, Schmitt WH, Weiss C, Habicht A, Renders L, Zeier M, Druschler F, Heller K, Pisarski P, Banas B, Kramer BK, Jung M, Lopau K, Olbricht CJ, Weihprecht H, Schenker P, De Fijter JW, Yard BA, Benck U. Effects of Dopamine Donor Pretreatment on Graft Survival after Kidney Transplantation: A Randomized Trial. Clin J Am Soc Nephrol. 2017 Mar 7;12(3):493-501. doi: 10.2215/CJN.07600716. Epub 2017 Feb 17.
- Benck U, Gottmann U, Hoeger S, Lammert A, Rose D, Boesebeck D, Lauchart W, Birck R, Weiss C, Kramer BK, Yard BA, Schnuelle P. Donor desmopressin is associated with superior graft survival after kidney transplantation. Transplantation. 2011 Dec 15;92(11):1252-8. doi: 10.1097/TP.0b013e318236cd4c.
- Benck U, Hoeger S, Brinkkoetter PT, Gottmann U, Doenmez D, Boesebeck D, Lauchart W, Gummert J, Karck M, Lehmkuhl HB, Bittner HB, Zuckermann A, Wagner F, Schulz U, Koch A, Bigdeli AK, Bara C, Hirt S, Berchtold-Herz M, Brose S, Herold U, Boehm J, Welp H, Strecker T, Doesch A, Birck R, Kramer BK, Yard BA, Schnuelle P. Effects of donor pre-treatment with dopamine on survival after heart transplantation: a cohort study of heart transplant recipients nested in a randomized controlled multicenter trial. J Am Coll Cardiol. 2011 Oct 18;58(17):1768-77. doi: 10.1016/j.jacc.2011.05.060.
- Schnuelle P, Gottmann U, Hoeger S, Boesebeck D, Lauchart W, Weiss C, Fischereder M, Jauch KW, Heemann U, Zeier M, Hugo C, Pisarski P, Kramer BK, Lopau K, Rahmel A, Benck U, Birck R, Yard BA. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA. 2009 Sep 9;302(10):1067-75. doi: 10.1001/jama.2009.1310.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dopamine | Small molecule | 4 ug/kg | — |